Total Payments
$2,991
2024 Payments
$46.45
Companies
27
Transactions
149
Medicare Patients
3,527
Medicare Billing
$566,036
Payment Breakdown by Category
Food & Beverage$2,888 (96.6%)
Education$99.00 (3.3%)
Gifts$3.99 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,888 | 147 | 96.6% |
| Education | $99.00 | 1 | 3.3% |
| Gift | $3.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $634.02 | 34 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $354.59 | 24 | $0 (2020) |
| Janssen Biotech, Inc. | $330.54 | 19 | $0 (2020) |
| TETRAPHASE PHARMACEUTICALS, INC. | $213.11 | 7 | $0 (2019) |
| Melinta Therapeutics, LLC | $177.96 | 8 | $0 (2020) |
| Janssen Products, LP | $173.05 | 2 | $0 (2019) |
| Allergan, Inc. | $167.32 | 10 | $0 (2020) |
| Gilead Sciences, Inc. | $140.54 | 8 | $0 (2020) |
| Theravance Biopharma, Inc. | $134.47 | 6 | $0 (2018) |
| Paratek Pharmaceuticals, Inc. | $78.32 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.45 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($24.64) |
| 2023 | $24.85 | 1 | ABBVIE INC. ($24.85) |
| 2020 | $349.54 | 16 | Paratek Pharmaceuticals, Inc. ($59.13) |
| 2019 | $1,026 | 45 | TETRAPHASE PHARMACEUTICALS, INC. ($213.11) |
| 2018 | $733.12 | 42 | Janssen Biotech, Inc. ($160.04) |
| 2017 | $811.28 | 43 | ViiV Healthcare Company ($242.63) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/29/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.06 | General |
| 09/11/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: ANTIBIOTIC | ||||||
| 06/04/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/16/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: ANTIBIOTIC | ||||||
| 03/27/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: HIV | ||||||
| 03/25/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: HIV | ||||||
| 03/19/2020 | Melinta Therapeutics, LLC | Orbactiv (Drug), Vabomere | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: ANTIBIOTICS | ||||||
| 03/12/2020 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/27/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/06/2020 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/30/2020 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: HIV | ||||||
| 01/23/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ANTIBIOTIC | ||||||
| 01/16/2020 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $54.46 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: HIV | ||||||
| 01/02/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: Antibiotic | ||||||
| 12/18/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.57 | General |
| 12/10/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $61.65 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 12/05/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 11/21/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug), Vabomere | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: ANTIBIOTICS | ||||||
| 11/14/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Respiratory | ||||||
| 11/13/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 678 | 1,008 | $169,401 | $98,342 |
| 2022 | 6 | 746 | 1,661 | $216,562 | $127,790 |
| 2021 | 6 | 984 | 1,857 | $255,613 | $157,804 |
| 2020 | 8 | 1,119 | 2,197 | $285,695 | $182,100 |
Total Patients
3,527
Total Services
6,723
Medicare Billing
$566,036
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 210 | 464 | $70,064 | $42,917 | 61.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 294 | 307 | $73,066 | $39,543 | 54.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 202 | $19,796 | $12,341 | 62.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $6,475 | $3,540 | 54.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 334 | 1,075 | $105,350 | $60,391 | 57.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 268 | 296 | $70,448 | $45,577 | 64.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 217 | $32,767 | $17,534 | 53.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 24 | $4,440 | $2,570 | 57.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 31 | $2,387 | $903.07 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 18 | $1,170 | $814.40 | 69.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 422 | 464 | $110,852 | $73,785 | 66.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 385 | 1,090 | $106,820 | $63,247 | 59.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 71 | 165 | $24,915 | $13,746 | 55.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $5,180 | $2,925 | 56.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 52 | $3,380 | $2,299 | 68.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 43 | 58 | $4,466 | $1,802 | 40.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 412 | 1,346 | $131,908 | $80,386 | 60.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 389 | 432 | $103,152 | $71,500 | 69.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 56 | 116 | $17,516 | $9,993 | 57.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 84 | 106 | $14,310 | $8,435 | 58.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 85 | 101 | $8,585 | $6,050 | 70.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 30 | 30 | $5,550 | $3,433 | 61.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 32 | 34 | $2,210 | $1,256 | 56.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 31 | 32 | $2,464 | $1,047 | 42.5% |
About Dr. John Piper, M.D
Dr. John Piper, M.D is a Infectious Disease healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083775654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Piper, M.D has received a total of $2,991 in payments from pharmaceutical and medical device companies, with $46.45 received in 2024. These payments were reported across 149 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,888).
As a Medicare-enrolled provider, Piper has provided services to 3,527 Medicare beneficiaries, totaling 6,723 services with total Medicare billing of $566,036. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Newark, DE
- Active Since 12/13/2006
- Last Updated 01/16/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1083775654
Products in Payments
- JULUCA (Drug) $360.37
- PREZCOBIX (Drug) $280.79
- Xerava (Drug) $213.11
- TRIUMEQ (Drug) $148.65
- VIBATIV (Drug) $134.47
- Symtuza (Drug) $118.39
- CUBICIN RF (Drug) $103.70
- AVYCAZ (Drug) $97.21
- DOVATO (Drug) $96.31
- ISENTRESS (Drug) $95.67
- Orbactiv (Drug) $85.83
- NUZYRA (Drug) $78.32
- Vabomere (Drug) $75.43
- PREZISTA (Drug) $67.27
- DALVANCE (Drug) $66.02
- ORBACTIV (Drug) $61.36
- NOXAFIL (Drug) $60.72
- CUTAQUIG (Biological) $54.46
- Arikayce (Drug) $37.68
- SYMTUZA (Drug) $37.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Newark
Dr. Jihad Slim, Md, MD
Infectious Disease — Payments: $2.2M
Infectious Disease $2.2M
Dr. Maria Szabela, Md, MD
Infectious Disease — Payments: $336,664
Infectious Disease $336,664
Sally Hodder, M.d, M.D
Infectious Disease — Payments: $93,382
Infectious Disease $93,382
Shobha Swaminathan, M.d, M.D
Infectious Disease — Payments: $78,788
Infectious Disease $78,788
Wanda Figueroa, M.d, M.D
Infectious Disease — Payments: $13,660
Infectious Disease $13,660
Alexander Stoler, M.d, M.D
Infectious Disease — Payments: $5,931
Infectious Disease $5,931